NO168579C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye 4-amino-4,5-dihydro-2-furan(thiofen)-carboxylsyrerog lavere alkylestere - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye 4-amino-4,5-dihydro-2-furan(thiofen)-carboxylsyrerog lavere alkylestere

Info

Publication number
NO168579C
NO168579C NO844066A NO844066A NO168579C NO 168579 C NO168579 C NO 168579C NO 844066 A NO844066 A NO 844066A NO 844066 A NO844066 A NO 844066A NO 168579 C NO168579 C NO 168579C
Authority
NO
Norway
Prior art keywords
furane
thiophen
dihydro
amino
preparation
Prior art date
Application number
NO844066A
Other languages
English (en)
Other versions
NO168579B (no
NO844066L (no
Inventor
Jerry L Adams
Brian W Metcalf
Bruce J Lippert
Gene W Holbert
Joseph P Burkhart
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO844066L publication Critical patent/NO844066L/no
Publication of NO168579B publication Critical patent/NO168579B/no
Publication of NO168579C publication Critical patent/NO168579C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
NO844066A 1983-10-11 1984-10-10 Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye 4-amino-4,5-dihydro-2-furan(thiofen)-carboxylsyrerog lavere alkylestere NO168579C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54074383A 1983-10-11 1983-10-11
US54074583A 1983-10-11 1983-10-11
US54074483A 1983-10-11 1983-10-11

Publications (3)

Publication Number Publication Date
NO844066L NO844066L (no) 1985-04-12
NO168579B NO168579B (no) 1991-12-02
NO168579C true NO168579C (no) 1992-03-11

Family

ID=27415337

Family Applications (1)

Application Number Title Priority Date Filing Date
NO844066A NO168579C (no) 1983-10-11 1984-10-10 Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye 4-amino-4,5-dihydro-2-furan(thiofen)-carboxylsyrerog lavere alkylestere

Country Status (15)

Country Link
EP (1) EP0145875B1 (no)
JP (1) JPS60104077A (no)
KR (1) KR890001008B1 (no)
AU (1) AU569915B2 (no)
CA (1) CA1241963A (no)
DE (1) DE3485514D1 (no)
DK (1) DK483684A (no)
ES (4) ES536669A0 (no)
GR (1) GR80568B (no)
HU (1) HU201038B (no)
IE (1) IE57589B1 (no)
IL (1) IL73109A (no)
NO (1) NO168579C (no)
NZ (1) NZ209803A (no)
PT (1) PT79336B (no)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1473757A (en) * 1974-08-05 1977-05-18 Teikoku Chem Ind Co Ltd Ureylenethiophanes and their related compounds and production thereof

Also Published As

Publication number Publication date
PT79336B (en) 1986-09-08
ES541636A0 (es) 1985-12-01
GR80568B (en) 1985-02-07
IL73109A (en) 1990-02-09
ES8602746A1 (es) 1985-12-01
IL73109A0 (en) 1984-12-31
KR890001008B1 (ko) 1989-04-18
DK483684D0 (da) 1984-10-10
IE57589B1 (en) 1993-01-13
ES8603857A1 (es) 1986-01-01
NO168579B (no) 1991-12-02
EP0145875A3 (en) 1988-03-02
KR850002969A (ko) 1985-05-28
JPH0587513B2 (no) 1993-12-16
DE3485514D1 (de) 1992-03-26
CA1241963A (en) 1988-09-13
NZ209803A (en) 1987-02-20
DK483684A (da) 1985-04-12
NO844066L (no) 1985-04-12
EP0145875A2 (en) 1985-06-26
ES536669A0 (es) 1986-01-01
ES541635A0 (es) 1985-12-01
HUT36813A (en) 1985-10-28
AU3389784A (en) 1985-04-18
ES8602747A1 (es) 1985-12-01
AU569915B2 (en) 1988-02-25
ES541637A0 (es) 1985-12-01
HU201038B (en) 1990-09-28
JPS60104077A (ja) 1985-06-08
ES8602731A1 (es) 1985-12-01
EP0145875B1 (en) 1992-02-19
PT79336A (en) 1984-11-01
IE842584L (en) 1985-04-11

Similar Documents

Publication Publication Date Title
NO164418C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive naftyridin- og kinolin-karboksylsyre-forbindelser.
NO153136C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive naftyridinderivater.
NO170023C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive alfa-glucosidaseinhibitorer
NO154346C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalazin-4-yl-eddiksyrederivater.
AU508983B2 (en) Hydantoin n-methyl esters of carboxylic acids
NO145881C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk virksomme acetohydroksamsyrer
NO800858L (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-amino-3-kinolincarboxylsyrederivater
DK261877A (da) Fremgangsmade til fremstilling af antibakterielt virksomme carboxylsyreestere
NO149733C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive acylderivater av carnitin
NO154426C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive trans-3-(4-okso-4h-kinazolin-3-yl)-2-propensyrederivater.
NO152654C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive derivater av 7-acylamido-3-cephem-4-karboksylsyre
NO167510C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenylkinolincarboxylsyrer
NO152005C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karboksylsyrederivater
NO145236C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive omega-aminocarboxylsyrederivater
NO178374C (no) Analogifremgangsmåte for fremstilling av nye terapeutisk aktive acetylcholinesteraseinhibitorer
NO812686L (no) Fremgangsmaate for fremstilling av kinolinkarboksylsyrederivater
NO141718C (no) Analogifremgangsmaate ved fremstilling av antibiotisk aktiv trans-12,13-desepoxy-12,13-dehydrorosaramicin og estere og salter derav
PL204554A1 (pl) Srodek do zwalczania szkodnikow i sposob wytwarzania nowych estrow kwasu cyklopropanokarboksylowego
NO152605C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-pyridyl- og 2-pyrimidylaminobenzoesyrer
NO151008C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nitroforbindelser
NO168579C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye 4-amino-4,5-dihydro-2-furan(thiofen)-carboxylsyrerog lavere alkylestere
NO165635C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive kinolinderivater.
NO831012L (no) Fremgangsmaate ved fremstilling av nye, terapeutisk aktive 2-beta-d-ribofuranosylselenazol-4-carboxamid
NO870482L (no) Fremgangsmaate ved fremstilling av nye karboksylsyreamider.
NO150878C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1-nafthyl-eddiksyrederivater